REG - Goodwin PLC - September 2024 Trading Update

GoodwinAnnouncement

25/09/2024 10:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240925:nRSY6252Fa&default-theme=true

RNS Number : 6252F  Goodwin PLC  25 September 2024

GOODWIN PLC
SEPTEMBER 2024 TRADING UPDATE

Trading

 

The Group's profitability and cash generation is continuing to move forward,
predominantly driven by the Mechanical Engineering Division's increased
activity levels of work flowing through the shop floor.  The performance
within the Refractory Engineering Division remains in line with last year.

 

Radiography Facility

Goodwin Steel Castings (GSC) has continued to win further contracts to supply
naval hull components, which has contributed to the Group workload as at the
end of August having increased to £298 million.  As a direct result of the
workload at GSC to supply high integrity castings, which typically require a
high degree of radiography non-destructive testing, the US Government has
agreed to fully fund the capital and training elements for a quantity of four
High Power 9 Mev radiographic facilities that will be installed on GSC's site
and in doing so has awarded GSC $14.5 million of grant funding.

This award allows us to increase our capacity to process and test the
increased volume of castings that have already been placed, along with
additional components that are expected to be ordered and delivered within
their desired timeframes.  The facilities will be owned and operated by GSC
and are expected to be fully operational by the end of 2025.  These
compliment the two existing radiography facilities on GSC's site that
currently operate 24 hours a day, 7 days a week.

Duvelco

Commissioning of the polyimide production plant is methodically underway and
progressing. This is a couple of months behind the internal schedule set 4
years ago. To date the system has been fully tested with water where it can be
and is now being charged with solvents that will enable the testing of the
back end of the system. A further update will be provided within the half year
statement in December.

Appointment of Non-Executive Director

To further support the growth of the Group, it is a pleasure to announce the
appointment of Christine McNamara as a Non-Executive Director with effect from
the 2nd October 2024 following the Annual General Meeting.

Christine comes with an extensive and varied career within the energy and
power sector.  As a qualified accountant she has held multiple FD/CFO roles
within large corporates, including Powergen, National Grid PLC and BG Group
plc (purchased by Shell plc in 2016).  In addition to sitting on multiple
boards and committees, Christine's executive career has been hands on with her
having spent over 17 years overseas growing regional businesses in Asia and
the Middle East.  Christine's responsibilities during her 25 years'
experience have included financial strategy, business performance, governance,
audit and risk management.

Following a thorough induction to the business over the last 4 months, we are
confident that her extensive listed company experience and exposure to a
variety of business aspects will be of significant benefit to the Company.

There is no information to be disclosed pursuant to Listing Rule UKLR 6.4.8 in
respect of the appointed Director.

T.J.W. Goodwin

Chairman

 

END

LEI: 213800N4T1NMSJ57B322

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTLAMLTMTTTMLI